Meadow Creek Investment Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Meadow Creek Investment Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-208	Closed	-$14K	–	1342
2018 Q1	$14K	Sell	208 -632	-75%	-$44.8K	﹤0.01%	1309
2017 Q4	$61K	Sell	840 -604	-42%	-$50K	﹤0.01%	1259
2017 Q3	$132K	Sell	1,444 -177	-11%	-$13.6K	﹤0.01%	1066
2017 Q2	$107K	Sell	1,621 -541	-25%	-$67K	﹤0.01%	1078
2017 Q1	$469K	Hold	2,162	–	–	0.01%	560
2016 Q4	$200K	Buy	+2,162	New	+$244K	0.01%	711

Other funds holding LUMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Meadow Creek Investment Management's LUMO Position: Q2 2018 in Review

Meadow Creek Investment Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 208 shares — an estimated $14K sold.

Meadow Creek Investment Management first reported a position in LUMO in Q4 2016 and held it in 6 quarters. The position peaked at $469K in Q1 2017. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

Meadow Creek Investment Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Meadow Creek Investment Management sold 208 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $14K.
Meadow Creek Investment Management first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2016 and held it in 6 quarters.
Meadow Creek Investment Management's Lumos Pharma, Inc. Common Stock position peaked at $469K in Q1 2017.
106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on Meadow Creek Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.